Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Sodium Thiosulfate · Pedmark, DB-020

Small molecule · Acts on cytochrome c oxidase (cytochrome a3) and rhodanese (thiosulfate sulfurtransferase) (TST) · developed by Us Army

Approved FDA, Feb 1992
1 Registered trials

What is Sodium Thiosulfate?

Sodium thiosulfate is an antidote that serves as a sulfur donor for rhodanese, enhancing the conversion of cyanide to thiocyanate, which is relatively nontoxic and readily excreted. It is used with sodium nitrite in acute cyanide poisoning and is also studied for reducing cisplatin-induced ototoxicity in children with solid tumors.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Pedmark, DB-020, NSC-45624
Drug type
Small molecule
Targets
cytochrome c oxidase (cytochrome a3), rhodanese (thiosulfate sulfurtransferase) (TST)
Mechanism
Acts on cytochrome c oxidase (cytochrome a3) and rhodanese (thiosulfate sulfurtransferase) (TST)
Pathways
cyanide detoxification to thiocyanate, aerobic metabolism restoration
Therapy area
Oncology
Developer
Us Army
In trials of
FENC
FDA status
Approved as Pedmark (February 14, 1992), NDA020166 · FDA label
UNII
HX1032V43M

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04132882 N/A Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma Available FENC

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Sources

Updated Nov 8, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.